Modified Plasmodium falciparum Ring-Stage Survival Assay with ML10 Kinase Inhibitor.

Lucien Platon ORCID logo; David A Baker ORCID logo; Didier Ménard ORCID logo; (2023) Modified Plasmodium falciparum Ring-Stage Survival Assay with ML10 Kinase Inhibitor. Antimicrobial agents and chemotherapy, 67 (5). e0001723. ISSN 0066-4804 DOI: 10.1128/aac.00017-23
Copy

The ring-stage survival assay is the reference assay to measure in vitro Plasmodium falciparum artemisinin partial resistance. The main challenge of the standard protocol is to generate 0-to-3-h postinvasion ring stages (the stage least susceptible to artemisinin) from schizonts obtained by sorbitol treatment and Percoll gradient. We report here a modified protocol facilitating the production of synchronized schizonts when multiple strains are tested simultaneously, by using ML10, a protein kinase inhibitor, that reversibly blocks merozoite egress.



picture_as_pdf
Platon-etal-2023-Modified-Plasmodium-falciparum-Ring-stage-Survival-Assay-with-ML10-kinase-inhibitor.pdf
subject
Accepted Version
Available under Creative Commons: 4.0

View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication: